• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

为患有特发性肺纤维化的非小细胞肺癌患者放疗后严重放射性肺炎发生率开发影像复杂性生物标志物的初步结果

Preliminary Results of Developing Imaging Complexity Biomarkers for the Incidence of Severe Radiation Pneumonitis Following Radiotherapy in Non-Small Cell Lung Cancer Patients with Underlying Idiopathic Pulmonary Fibrosis.

作者信息

Hwang Jeongeun, Kim Hakyoung, Kim Sun Myung, Yang Dae Sik

机构信息

Department of Medical IT Engineering, Soonchunhyang University, Asan 31538, Chungcheongnam-do, Republic of Korea.

Departments of Radiation Oncology, Korea University Guro Hospital, Korea University College of Medicine, Seoul 08308, Republic of Korea.

出版信息

Life (Basel). 2024 Jul 19;14(7):897. doi: 10.3390/life14070897.

DOI:10.3390/life14070897
PMID:39063650
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11277958/
Abstract

Idiopathic pulmonary fibrosis (IPF) has the potential to cause fatal pulmonary toxicity after radiotherapy and can increase the morbidity and mortality of non-small-cell lung cancer (NSCLC) patients. In this context, we aimed to develop imaging complexity biomarkers to predict the incidence of severe pulmonary toxicity in patients with NSCLC who have underlying IPF and are treated with radiotherapy. We retrospectively reviewed the medical records of 19 patients with NSCLC who had underlying IPF and were treated with radiotherapy at the Korea University Guro Hospital between March 2018 and December 2022. To quantify the morphometric complexity of the lung parenchyma, box-counting fractal dimensions and lacunarity analyses were performed on pre-radiotherapy simulation chest computed tomography scans. Of the 19 patients, the incidence of grade 3 or higher radiation pneumonitis was observed in 8 (42.1%). After adjusting for age, sex, smoking status, histology, and diffusing capacity of the lung for carbon monoxide, eight patients with a lower fractal dimension showed a significantly higher hazard ratio of 7.755 (1.168-51.51) for grade 3 or higher pneumonitis than those with a higher fractal dimension. Patients with lower lacunarity exhibited significantly lower hazards in all models, both with and without adjustments. The lower-than-median lacunarity group also showed significantly lower incidence curves for all models built in this study. We devised a technique for quantifying morphometric complexity in NSCLC patients with IPF on radiotherapy and discovered lacunarity as a potential imaging biomarker for grade 3 or higher pneumonitis.

摘要

特发性肺纤维化(IPF)在放疗后有可能导致致命的肺部毒性,并会增加非小细胞肺癌(NSCLC)患者的发病率和死亡率。在此背景下,我们旨在开发影像复杂性生物标志物,以预测患有潜在IPF且接受放疗的NSCLC患者发生严重肺部毒性的几率。我们回顾性分析了2018年3月至2022年12月期间在韩国大学古罗医院接受放疗的19例患有潜在IPF的NSCLC患者的病历。为了量化肺实质的形态计量复杂性,我们对放疗前模拟胸部计算机断层扫描进行了盒计数分形维数和孔隙率分析。在这19例患者中,8例(42.1%)出现了3级或更高等级的放射性肺炎。在调整了年龄、性别、吸烟状况、组织学类型和肺一氧化碳弥散量后,8例分形维数较低的患者发生3级或更高等级肺炎的风险比为7.755(1.168 - 51.51),显著高于分形维数较高的患者。在所有模型中,无论是否进行调整,孔隙率较低的患者风险均显著较低。低于中位数孔隙率组在本研究构建的所有模型中发病率曲线也显著较低。我们设计了一种技术来量化接受放疗的IPF合并NSCLC患者的形态计量复杂性,并发现孔隙率是3级或更高等级肺炎的潜在影像生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5435/11277958/f32f8835dcd8/life-14-00897-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5435/11277958/8229c67558e5/life-14-00897-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5435/11277958/f32f8835dcd8/life-14-00897-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5435/11277958/8229c67558e5/life-14-00897-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5435/11277958/f32f8835dcd8/life-14-00897-g002.jpg

相似文献

1
Preliminary Results of Developing Imaging Complexity Biomarkers for the Incidence of Severe Radiation Pneumonitis Following Radiotherapy in Non-Small Cell Lung Cancer Patients with Underlying Idiopathic Pulmonary Fibrosis.为患有特发性肺纤维化的非小细胞肺癌患者放疗后严重放射性肺炎发生率开发影像复杂性生物标志物的初步结果
Life (Basel). 2024 Jul 19;14(7):897. doi: 10.3390/life14070897.
2
Risk factor analysis of the development of severe radiation pneumonitis in patients with non-small cell lung cancer treated with curative radiotherapy, with focus on underlying pulmonary disease.根治性放疗治疗非小细胞肺癌患者发生重度放射性肺炎的危险因素分析,重点在于基础肺部疾病。
BMC Cancer. 2023 Oct 17;23(1):992. doi: 10.1186/s12885-023-11520-y.
3
[Radiotherapy of Lung Tumours in Idiopathic Pulmonary Fibrosis].[特发性肺纤维化中肺肿瘤的放射治疗]
Klin Onkol. 2017 Summer;30(4):303-306. doi: 10.14735/amko2017303.
4
Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation.非小细胞肺癌合并肺纤维化肺气肿和特发性肺纤维化:对生存和急性加重的影响。
BMC Pulm Med. 2019 Oct 15;19(1):177. doi: 10.1186/s12890-019-0951-2.
5
Is Thoracic Radiotherapy an Absolute Contraindication for Treatment of Lung Cancer Patients With Interstitial Lung Disease? A Systematic Review.胸部放射治疗是否为间质性肺疾病肺癌患者治疗的绝对禁忌证?系统评价。
Clin Oncol (R Coll Radiol). 2022 Dec;34(12):e493-e504. doi: 10.1016/j.clon.2022.01.043. Epub 2022 Feb 12.
6
Acute severe radiation pneumonitis among non-small cell lung cancer (NSCLC) patients with moderate pulmonary dysfunction receiving definitive concurrent chemoradiotherapy: Impact of pre-treatment pulmonary function parameters.中重度肺功能障碍的非小细胞肺癌(NSCLC)患者接受根治性同期放化疗后发生急性重度放射性肺炎:治疗前肺功能参数的影响。
Strahlenther Onkol. 2020 Jun;196(6):505-514. doi: 10.1007/s00066-019-01552-4. Epub 2019 Dec 11.
7
Safety and efficacy of CT-guided percutaneous microwave ablation for stage I non-small cell lung cancer in patients with comorbid idiopathic pulmonary fibrosis.CT引导下经皮微波消融治疗合并特发性肺纤维化的Ⅰ期非小细胞肺癌的安全性和有效性
Eur Radiol. 2024 Jul;34(7):4708-4715. doi: 10.1007/s00330-023-10510-9. Epub 2023 Dec 20.
8
Histologic Analysis of Idiopathic Pulmonary Fibrosis by Morphometric and Fractal Analysis.通过形态计量学和分形分析对特发性肺纤维化进行组织学分析。
Biomedicines. 2023 May 19;11(5):1483. doi: 10.3390/biomedicines11051483.
9
Preliminary result of definitive radiotherapy in patients with non-small cell lung cancer who have underlying idiopathic pulmonary fibrosis: comparison between X-ray and proton therapy.特发性肺纤维化合并非小细胞肺癌根治性放疗的初步结果:X 射线与质子治疗的比较。
Radiat Oncol. 2019 Jan 28;14(1):19. doi: 10.1186/s13014-019-1221-4.
10
Idiopathic pulmonary fibrosis in patients with early-stage non-small-cell lung cancer after surgical resection.手术切除后早期非小细胞肺癌患者的特发性肺纤维化
Radiol Oncol. 2019 Sep 24;53(3):357-361. doi: 10.2478/raon-2019-0032.

引用本文的文献

1
Efficacy and safety of immune checkpoint inhibitors combined with iodine-125 seed implantation in driver gene-negative non-small cell lung cancer: a retrospective cohort study.免疫检查点抑制剂联合碘-125粒子植入治疗驱动基因阴性非小细胞肺癌的疗效与安全性:一项回顾性队列研究
J Thorac Dis. 2025 Jan 24;17(1):278-288. doi: 10.21037/jtd-24-1403. Epub 2025 Jan 22.

本文引用的文献

1
Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis.抗纤维化药物尼达尼布和吡非尼酮治疗特发性肺纤维化(IPF)和非特发性肺纤维化(非 IPF)进展性肺纤维化的疗效:系统评价和荟萃分析。
BMC Pulm Med. 2021 Dec 11;21(1):411. doi: 10.1186/s12890-021-01783-1.
2
Risk factors for radiation pneumonitis in lung cancer patients with subclinical interstitial lung disease after thoracic radiation therapy.胸部放射治疗后亚临床间质性肺疾病的肺癌患者放射性肺炎的危险因素。
Radiat Oncol. 2021 Apr 13;16(1):70. doi: 10.1186/s13014-021-01798-2.
3
Antifibrotic drugs for idiopathic pulmonary fibrosis: What we should know?
用于特发性肺纤维化的抗纤维化药物:我们应该了解什么?
Indian J Med Res. 2020 Sep;152(3):177-180. doi: 10.4103/ijmr.IJMR_90_20.
4
Repurposing Anticancer Drugs for the Treatment of Idiopathic Pulmonary Fibrosis and Antifibrotic Drugs for the Treatment of Cancer: State of the Art.抗癌药物再利用治疗特发性肺纤维化和抗纤维化药物治疗癌症:现状。
Curr Med Chem. 2021;28(11):2234-2247. doi: 10.2174/0929867327999200730173748.
5
Impact Of Underlying Pulmonary Diseases On Treatment Outcomes In Early-Stage Non-Small Cell Lung Cancer Treated With Definitive Radiotherapy.基础肺部疾病对接受根治性放疗的早期非小细胞肺癌治疗结果的影响。
Int J Chron Obstruct Pulmon Dis. 2019 Oct 4;14:2273-2281. doi: 10.2147/COPD.S210759. eCollection 2019.
6
Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation.非小细胞肺癌合并肺纤维化肺气肿和特发性肺纤维化:对生存和急性加重的影响。
BMC Pulm Med. 2019 Oct 15;19(1):177. doi: 10.1186/s12890-019-0951-2.
7
Preliminary result of definitive radiotherapy in patients with non-small cell lung cancer who have underlying idiopathic pulmonary fibrosis: comparison between X-ray and proton therapy.特发性肺纤维化合并非小细胞肺癌根治性放疗的初步结果:X 射线与质子治疗的比较。
Radiat Oncol. 2019 Jan 28;14(1):19. doi: 10.1186/s13014-019-1221-4.
8
Low morphometric complexity of emphysematous lesions predicts survival in chronic obstructive pulmonary disease patients.肺气肿病变的低形态复杂性预测慢性阻塞性肺疾病患者的生存。
Eur Radiol. 2019 Jan;29(1):176-185. doi: 10.1007/s00330-018-5551-7. Epub 2018 Jun 29.
9
Total Airway Count on Computed Tomography and the Risk of Chronic Obstructive Pulmonary Disease Progression. Findings from a Population-based Study.基于人群研究的 CT 气道总计数与慢性阻塞性肺疾病进展风险。
Am J Respir Crit Care Med. 2018 Jan 1;197(1):56-65. doi: 10.1164/rccm.201704-0692OC.
10
A size-based emphysema severity index: robust to the breath-hold-level variations and correlated with clinical parameters.一种基于大小的肺气肿严重程度指数:对屏气水平变化具有稳健性且与临床参数相关。
Int J Chron Obstruct Pulmon Dis. 2016 Aug 3;11:1835-41. doi: 10.2147/COPD.S109846. eCollection 2016.